- Raised $12M Series B led by Carl Zeiss, Jun 2022
- Raised $15.5M debt round led by K20 Fund, Jun 2022
- Raised $10M Series A led by Aurum Ventures M.K.I, Aug 2017
About
Precise Bio is a clinical-stage regenerative medicine company pioneering a proprietary 3D-bio-fabrication platform that integrates cell biology and biomaterials to produce clinical-grade human tissues under GMP conditions. The company's commercial and R&D programs are based on its innovative 4D-bio-fabrication technology, which comprises cell expansion, biomaterials, processes, printing technology, and other critical technologies. Precise Bio is advancing the use of bio-printed tissues and organs in patients in ophthalmology, with a lead program in cornea grafts, and is building a broad portfolio of R&D programs in additional medical disciplines. The company maintains offices, laboratories, and production facilities in North Carolina, in the U.S. and in Shoham, Israel, and its GMP facility is located in Sheba Medical Center, near Tel Aviv, Israel.
Funding history · 4 rounds · $37.5M total
Headcount over time
Q&A
- What is Precise Bio's primary focus?
- Precise Bio is a regenerative medicine company that uses bio-printed tissues and organs, primarily for ophthalmology patients.
- When was Precise Bio founded?
- Precise Bio was founded in July 2015.
- How many employees does Precise Bio currently have?
- Precise Bio has 11-50 employees.
- What is Precise Bio's total funding to date?
- Precise Bio has raised a total of $37.53 million USD.
- When did Precise Bio complete its most recent funding round?
- Precise Bio completed a B Round in January 2024, raising $12 million USD. Carl Zeiss Meditec was among the investors.
- What is the core technology behind Precise Bio's products?
- Precise Bio's commercial and R&D programs are based on its proprietary 4D-bio-fabrication platform, which integrates cell expansion, biomaterials, processes, and printing technology.
- Where are Precise Bio's main facilities located?
- Precise Bio maintains offices, laboratories, and production facilities in North Carolina, USA, and Shoham, Israel. Its GMP facility is located in Sheba Medical Center, near Tel Aviv, Israel.
- What was a significant partnership announced by Precise Bio in 2022?
- In July 2022, Carl Zeiss Meditec and Precise Bio announced a partnership for the development and commercialization of tissue-based implants for ophthalmology.
Team · 3
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | precise-bio.com |
|---|---|
| linkedin.com/company/10439616 | |
| YouTube | youtube.com/channel/UCTF-I1siiWbwvz3YUbO_Umg |
Identifiers & details
| Legal name | Precise Bio, Inc. |
|---|---|
| Founded | 2015-7 |
| Employees (exact) | 42 |
| Offices | Winston-Salem |
Radar intelligence
Patents
| EPO | 18 |
|---|
Web history (Wayback)
| Domain | precise-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515437358 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-04-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | הגנן 1 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-12 | דו~ח שנתי |